Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Japan Tissue Engineering Co., Ltd. ( (JP:7774) ) is now available.
Japan Tissue Engineering Co., Ltd. reported a decrease in net sales and net income for the third quarter of FY2024 compared to the previous year, reflecting ongoing financial challenges. The company has revised its forecasts for FY2024, indicating a cautious outlook amid a competitive market environment, which could have implications for its stakeholders and market position.
More about Japan Tissue Engineering Co., Ltd.
Japan Tissue Engineering Co., Ltd. operates in the biotechnology industry, focusing on regenerative medicine. The company primarily develops tissue engineering products and services, aiming to advance medical treatments and improve patient outcomes.
YTD Price Performance: 6.91%
Average Trading Volume: 35,291
Technical Sentiment Consensus Rating: Buy
Current Market Cap: Yen20.1B
Find detailed analytics on 7774 stock on TipRanks’ Stock Analysis page.